Form 8-K - Current report:
SEC Accession No. 0001398733-25-000030
Filing Date
2025-11-06
Accepted
2025-11-06 16:01:52
Documents
24
Period of Report
2025-11-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20251106.htm   iXBRL 8-K 27975
2 EX-99.1 q32025supplementalearnin.htm EX-99.1 17951
6 q32025supplementalearnin001.jpg GRAPHIC 104241
7 q32025supplementalearnin002.jpg GRAPHIC 289531
8 q32025supplementalearnin003.jpg GRAPHIC 144682
9 q32025supplementalearnin004.jpg GRAPHIC 124417
10 q32025supplementalearnin005.jpg GRAPHIC 112616
11 q32025supplementalearnin006.jpg GRAPHIC 72300
12 q32025supplementalearnin007.jpg GRAPHIC 40272
13 q32025supplementalearnin008.jpg GRAPHIC 69842
14 q32025supplementalearnin009.jpg GRAPHIC 92240
15 q32025supplementalearnin010.jpg GRAPHIC 64218
16 q32025supplementalearnin011.jpg GRAPHIC 37241
  Complete submission text file 0001398733-25-000030.txt   1755839

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20251106.xsd EX-101.SCH 1776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20251106_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20251106_pre.xml EX-101.PRE 12504
26 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20251106_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 251458060
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)